Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2017 Update

Summary

Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research areas. Its clinical areas include bone metabolism, calcium metabolism, chronic kidney disease and mineral bone disorders, fertility, growth disorders, and cartilage markers. IDS offers IDS-iSYS multi-discipline automated system, an instrument based on chemiluminescence and absorbency technology to improve productivity and efficiency of specialty immunoassay testing in laboratories of all types and volumes. The company offers services such as application training and advice, customized training, qualified customer care centers and regionalised proximity teams. It has operations in the UK, Italy, Australia, Japan, Germany, France, Norway, Belgium and the US. IDS is headquartered in Tyne and Wear, the UK.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Immunodiagnostic Systems Holdings plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Immunodiagnostic Systems Holdings plc Company Overview 5
Immunodiagnostic Systems Holdings plc Company Snapshot 5
Immunodiagnostic Systems Holdings plc Pipeline Products and Ongoing Clinical Trials Overview 5
Immunodiagnostic Systems Holdings plc Pipeline Analysis Overview 8
Immunodiagnostic Systems Holdings plc - Key Facts 8
Immunodiagnostic Systems Holdings plc - Major Products and Services 9
Immunodiagnostic Systems Holdings plc Pipeline Products by Development Stage 10
Immunodiagnostic Systems Holdings plc Pipeline Products Overview 12
IDS-iSYS - 17-beta Estradiol Assay 12
IDS-iSYS - 17-beta Estradiol Assay Product Overview 12
IDS-iSYS - Intact PINP Assay 13
IDS-iSYS - Intact PINP Assay Product Overview 13
IDS-iSYS - Total Testosterone Assay 14
IDS-iSYS - Total Testosterone Assay Product Overview 14
IDS-iSYS Bioactive PTH (1-84) Kit 15
IDS-iSYS Bioactive PTH (1-84) Kit Product Overview 15
IDS-iSYS Cortisol Assay 16
IDS-iSYS Cortisol Assay Product Overview 16
IDS-iSYS Free Testosterone Assay 17
IDS-iSYS Free Testosterone Assay Product Overview 17
IDS-iSYS Intact PINP Assay 18
IDS-iSYS Intact PINP Assay Product Overview 18
IDS-iSYS MGP Assay 19
IDS-iSYS MGP Assay Product Overview 19
IDS-iSYS N-MID Osteocalcin Assay 20
IDS-iSYS N-MID Osteocalcin Assay Product Overview 20
IDS-iSYS Ostase BAP Assay 21
IDS-iSYS Ostase BAP Assay Product Overview 21
Immunodiagnostic Systems Holdings plc - Key Competitors 22
Immunodiagnostic Systems Holdings plc - Key Employees 23
Immunodiagnostic Systems Holdings plc - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 26
Immunodiagnostic Systems Holdings plc, Recent Developments 26
Oct 31, 2017: Immunodiagnostic Systems Holdings: Directorate Change 26
Oct 20, 2017: Immunodiagnostic Systems Holdings: H1 Trading Update 2017 26
Aug 10, 2017: Launch of IDS-iSYS Free Testosterone assay - New Assay In The IDS Fertility Portfolio 27
Jun 21, 2017: Immunodiagnostic Systems Holdings: Final Results for year ended 31 March 2017 27
Mar 13, 2017: Immunodiagnostic Systems Holdings Re-Appoints CEO 28
Mar 01, 2017: Immunodiagnostic Systems Holdings Announces Launch of IDS-iSYS InaKtif MGP assay - new assay in the IDS CKD-MDB portfolio 28
Feb 24, 2017: Immunodiagnostic Systems Holdings: Update on CEO Appointment 28
Jan 27, 2017: Omega Diagnostics Group: Update on discussions with Immunodiagnostic Systems Holdings 28
Jan 19, 2017: Immunodiagnostic Systems Holdings Announces Directorate Change 29
Nov 25, 2016: Immunodiagnostic Systems Holdings: Interim Results for the six month period ended 30 September 2016 29
Appendix 31
Methodology 31
About GlobalData 34
Contact Us 34
Disclaimer 34

List Of Tables


Immunodiagnostic Systems Holdings plc Pipeline Products and Ongoing Clinical Trials Overview 5
Immunodiagnostic Systems Holdings plc Pipeline Products by Equipment Type 6
Immunodiagnostic Systems Holdings plc Pipeline Products by Indication 7
Immunodiagnostic Systems Holdings plc, Key Facts 8
Immunodiagnostic Systems Holdings plc, Major Products and Services 9
Immunodiagnostic Systems Holdings plc Number of Pipeline Products by Development Stage 10
Immunodiagnostic Systems Holdings plc Pipeline Products Summary by Development Stage 11
IDS-iSYS - 17-beta Estradiol Assay - Product Status 12
IDS-iSYS - 17-beta Estradiol Assay - Product Description 12
IDS-iSYS - Intact PINP Assay - Product Status 13
IDS-iSYS - Intact PINP Assay - Product Description 13
IDS-iSYS - Total Testosterone Assay - Product Status 14
IDS-iSYS - Total Testosterone Assay - Product Description 14
IDS-iSYS Bioactive PTH (1-84) Kit - Product Status 15
IDS-iSYS Bioactive PTH (1-84) Kit - Product Description 15
IDS-iSYS Cortisol Assay - Product Status 16
IDS-iSYS Cortisol Assay - Product Description 16
IDS-iSYS Free Testosterone Assay - Product Status 17
IDS-iSYS Free Testosterone Assay - Product Description 17
IDS-iSYS Intact PINP Assay - Product Status 18
IDS-iSYS Intact PINP Assay - Product Description 18
IDS-iSYS MGP Assay - Product Status 19
IDS-iSYS MGP Assay - Product Description 19
IDS-iSYS N-MID Osteocalcin Assay - Product Status 20
IDS-iSYS N-MID Osteocalcin Assay - Product Description 20
IDS-iSYS Ostase BAP Assay - Product Status 21
IDS-iSYS Ostase BAP Assay - Product Description 21
Immunodiagnostic Systems Holdings plc, Key Employees 23
Immunodiagnostic Systems Holdings plc, Other Locations 24
Immunodiagnostic Systems Holdings plc, Subsidiaries 24
Glossary 33

List Of Figures


Immunodiagnostic Systems Holdings plc Pipeline Products by Equipment Type 6
Immunodiagnostic Systems Holdings plc Pipeline Products by Development Stage 10

Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2018 Update

Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone

USD 750 View Report

Immunodiagnostic Systems Holdings plc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Immunodiagnostic Systems Holdings plc Company Profile is a detailed strategic and analytical report on Immunodiagnostic Systems Holdings plc. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2018 Update

Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone

USD 750 View Report

Spirit AeroSystems Holdings, Inc. - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Spirit AeroSystems Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Spirit AeroSystems Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes

USD 350 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available